BSE filing, NSE: PANAFIC. Summary written from the filing by ALFA Finder's alert engine.
Panafic Industrials Ltd: key numbers
- Share price
- ₹2.16
- Market cap
- ₹106.4 Cr
- Revenue (annual)
- ₹0.76 Cr
- Net profit (annual)
- ₹-2.37 Cr
- P/E (TTM)
- 62.1×Sector 19.7×
- Promoter holding
- 16.40%+0.00% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Panafic Industrials Ltd
All →Panafic Industrials Other Announcement
Panafic Industrials Ltd submitted its quarterly shareholding pattern for the period ended September 30, 2026, pursuant to Regulation 31. The filing provides current promoter and public holdings.
Panafic Industrials Management Change
Panafic Investment and Finance's board approved filing an application with the RBI to seek prior approval for appointing Mr. Ankit Sharma as an Additional Director.
Panafic Industrials Other Announcement
Panafic Industrials Ltd filed its quarterly compliance certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended September 30, 2026.
Panafic Industrials Annual General Meeting
Panafic Industrials Ltd held its 41st Annual General Meeting on September 11, 2026. The meeting transacted business items including adoption of financial statements and name change.
Panafic Industrials Annual General Meeting
Panafic Industrials Ltd. scheduled its 41st Annual General Meeting for September 11, 2026. The company will close its register of members from September 5 to September 11, 2026.
Panafic Industrials Board Meeting Outcome
Panafic Industrials Ltd's board approved changing the company name to 'Panafic Investment and Finance Limited'. The board also scheduled the 41st AGM for September 11, 2026.
Other board meeting date announcements
All →Patel Engineering Board Meeting Date
Patel Engineering has scheduled its Board meeting for November 5, 2026, to approve Q1 and H1 FY27 unaudited results. No financial figures or decisions are reported in this advance notice.
GKB Ophthalmics Board Meeting Date
GKB Ophthalmics scheduled its Board Meeting for November 12, 2026. The meeting will consider approving unaudited results for the September 30, 2026 quarter and half year.
Bombay Oxygen Investments Board Meeting Date
Board meeting scheduled for Nov 6, 2026 to approve Q1 and H1 FY27 unaudited results. Trading window closed for insiders Oct 1–Nov 8, 2026.
OCCL Board Meeting Date
OCCL Ltd has scheduled its Board meeting for 6 November 2026 to consider Q1 FY27 unaudited results and a possible interim dividend. The trading window for designated persons closed from 1 October 2026.
TCM Board Meeting Date
TCM Limited intimated a Board meeting for 06/11/2026 to approve Q2 FY27 results. The trading window will reopen 48 hours after the results declaration.
Mercury Laboratories Board Meeting Date
Mercury Laboratories scheduled its Board meeting for November 5, 2026, to approve Q2/H1 FY27 results. Trading window remains closed until 48 hours post-announcement.